IBDEI0GF ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16465,1,3,0)
 ;;=3^Myelobl Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,16465,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,16465,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,16466,0)
 ;;=C92.40^^67^801^30
 ;;^UTILITY(U,$J,358.3,16466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16466,1,3,0)
 ;;=3^Promyelocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,16466,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,16466,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,16467,0)
 ;;=C92.50^^67^801^27
 ;;^UTILITY(U,$J,358.3,16467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16467,1,3,0)
 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,16467,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,16467,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,16468,0)
 ;;=C78.7^^67^801^36
 ;;^UTILITY(U,$J,358.3,16468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16468,1,3,0)
 ;;=3^Secondary Malig Neop Liver & Intrahep BD
 ;;^UTILITY(U,$J,358.3,16468,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,16468,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,16469,0)
 ;;=C91.10^^67^801^4
 ;;^UTILITY(U,$J,358.3,16469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16469,1,3,0)
 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
 ;;^UTILITY(U,$J,358.3,16469,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,16469,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,16470,0)
 ;;=D46.9^^67^801^26
 ;;^UTILITY(U,$J,358.3,16470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16470,1,3,0)
 ;;=3^Myelodysplastic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,16470,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,16470,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,16471,0)
 ;;=C79.31^^67^801^33
 ;;^UTILITY(U,$J,358.3,16471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16471,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,16471,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,16471,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,16472,0)
 ;;=C79.32^^67^801^34
 ;;^UTILITY(U,$J,358.3,16472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16472,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,16472,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,16472,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,16473,0)
 ;;=G89.3^^67^801^29
 ;;^UTILITY(U,$J,358.3,16473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16473,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,16473,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,16473,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,16474,0)
 ;;=C79.82^^67^801^35
 ;;^UTILITY(U,$J,358.3,16474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16474,1,3,0)
 ;;=3^Secondary Malig Neop Genital Organs
 ;;^UTILITY(U,$J,358.3,16474,1,4,0)
 ;;=4^C79.82
 ;;^UTILITY(U,$J,358.3,16474,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,16475,0)
 ;;=I50.9^^67^802^7
 ;;^UTILITY(U,$J,358.3,16475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16475,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,16475,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,16475,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,16476,0)
 ;;=I73.9^^67^802^13
 ;;^UTILITY(U,$J,358.3,16476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16476,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16476,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,16476,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,16477,0)
 ;;=I35.0^^67^802^11
 ;;^UTILITY(U,$J,358.3,16477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16477,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,16477,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,16477,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,16478,0)
 ;;=I35.1^^67^802^10
 ;;^UTILITY(U,$J,358.3,16478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16478,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,16478,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,16478,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,16479,0)
 ;;=I35.2^^67^802^12
 ;;^UTILITY(U,$J,358.3,16479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16479,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,16479,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,16479,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,16480,0)
 ;;=I35.9^^67^802^9
 ;;^UTILITY(U,$J,358.3,16480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16480,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16480,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16480,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16481,0)
 ;;=I42.7^^67^802^3
 ;;^UTILITY(U,$J,358.3,16481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16481,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/External Agent
 ;;^UTILITY(U,$J,358.3,16481,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,16481,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,16482,0)
 ;;=I21.3^^67^802^14
 ;;^UTILITY(U,$J,358.3,16482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16482,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,16482,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,16482,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,16483,0)
 ;;=I25.5^^67^802^8
 ;;^UTILITY(U,$J,358.3,16483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16483,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,16483,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,16483,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,16484,0)
 ;;=I25.9^^67^802^6
 ;;^UTILITY(U,$J,358.3,16484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16484,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16484,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,16484,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,16485,0)
 ;;=I25.10^^67^802^2
 ;;^UTILITY(U,$J,358.3,16485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16485,1,3,0)
 ;;=3^Athscl Hrt Dis Ntv Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,16485,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16485,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16486,0)
 ;;=D64.9^^67^802^1
 ;;^UTILITY(U,$J,358.3,16486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16486,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16486,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16486,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16487,0)
 ;;=I42.9^^67^802^4
 ;;^UTILITY(U,$J,358.3,16487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16487,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16487,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,16487,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,16488,0)
 ;;=I67.9^^67^802^5
 ;;^UTILITY(U,$J,358.3,16488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16488,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16488,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,16488,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,16489,0)
 ;;=F04.^^67^803^2
 ;;^UTILITY(U,$J,358.3,16489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16489,1,3,0)
 ;;=3^Amnestic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16489,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,16489,2)
 ;;=^5003051
 ;;^UTILITY(U,$J,358.3,16490,0)
 ;;=F05.^^67^803^3
 ;;^UTILITY(U,$J,358.3,16490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16490,1,3,0)
 ;;=3^Delirium d/t Phsyiological Condition
 ;;^UTILITY(U,$J,358.3,16490,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,16490,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,16491,0)
 ;;=F06.8^^67^803^6
 ;;^UTILITY(U,$J,358.3,16491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16491,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16491,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,16491,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,16492,0)
 ;;=F32.9^^67^803^5
 ;;^UTILITY(U,$J,358.3,16492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16492,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,16492,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,16492,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,16493,0)
 ;;=R41.82^^67^803^1
 ;;^UTILITY(U,$J,358.3,16493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16493,1,3,0)
 ;;=3^Altered Mental Status,Unspec
